Anderson Hoagland & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7M | Buy |
22,691
+44
| +0.2% | +$34.3K | 1.69% | 14 |
|
|
2025
Q1 | $16.4M | Hold |
22,647
| – | – | 1.95% | 14 |
|
|
2024
Q4 | $16.4M | Sell |
22,647
-132
| -0.6% | -$95.8K | 1.69% | 15 |
|
|
2024
Q3 | $20.2M | Sell |
22,779
-27
| -0.1% | -$24K | 2.06% | 14 |
|
|
2024
Q2 | $21.3M | Sell |
22,806
-17
| -0.1% | -$15.9K | 2.23% | 10 |
|
|
2024
Q1 | $17.4M | Buy |
22,823
+260
| +1% | +$198K | 1.95% | 14 |
|
|
2023
Q4 | $14.3M | Hold |
22,563
| – | – | 1.76% | 17 |
|
|
2023
Q3 | $12.1M | Buy |
22,563
+668
| +3% | +$359K | 1.62% | 16 |
|
|
2023
Q2 | $10.3M | Hold |
21,895
| – | – | 1.32% | 20 |
|
|
2023
Q1 | $7.52M | Buy |
21,895
+407
| +2% | +$140K | 1.08% | 25 |
|
|
2022
Q4 | $7.54M | Buy |
21,488
+778
| +4% | +$273K | 1.1% | 27 |
|
|
2022
Q3 | $6.7M | Buy |
20,710
+1,919
| +10% | +$621K | 1.07% | 29 |
|
|
2022
Q2 | $6.16M | Buy |
18,791
+6,073
| +48% | +$1.99M | 0.93% | 31 |
|
|
2022
Q1 | $3.64M | Sell |
12,718
-114
| -0.9% | -$32.6K | 0.47% | 54 |
|
|
2021
Q4 | $3.09M | Buy |
12,832
+163
| +1% | +$39.2K | 0.4% | 62 |
|
|
2021
Q3 | $2.93M | Sell |
12,669
-102
| -0.8% | -$23.6K | 0.37% | 68 |
|
|
2021
Q2 | $2.93M | Buy |
12,771
+156
| +1% | +$35.8K | 0.37% | 69 |
|
|
2021
Q1 | $2.36M | Hold |
12,615
| – | – | 0.33% | 73 |
|
|
2020
Q4 | $2.13M | Buy |
12,615
+5,567
| +79% | +$940K | 0.34% | 72 |
|
|
2020
Q3 | $1.06M | Buy |
+7,048
| New | +$1.06M | 0.51% | 54 |
|